Know Cancer’s Next Move: Using ctDNA to guide treatment decisions in patients with GI Cancer
Fill form to unlock content
Loading, please wait
Error - something went wrong!
Please fill out form to access this item.
Thank you!
This webinar will explore the expanding role of circulating tumor DNA (ctDNA) for assessing molecular residual disease (MRD) and monitoring treatment response in patients with colorectal cancer.